BridgeMD
New treatment option for Fracture Femur
Official title Feasibility of Integrating Local Vibration Into Rehabilitation of Elderly Patients After Hip Fracture
ClinicalTrials.gov ID: NCT07309965
What this study is testing
- What it's testing
- Fractures of the upper end of the femur in elderly patients are the 2nd most common fracture. A fracture leads to a syndrome of psychomotor maladjustment, encouraged by pain and aggravated by hospitalisation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 75 and older
You may be able to join if
- Patients aged 75 or over who have undergone surgery for a fracture of the upper end of the femur
- Hospitalised in the SMR department no later than D14 of their operation
- Resource Iso Group greater than or equal to 3 on the Aggir scale
- Patient capable of consenting who has signed a consent form or patient unable to express consent at the discretion of the principal investigator...
- Affiliated to a social security scheme
You likely can't join if
- Persons deprived of their liberty by a judicial or administrative decision
- Individuals with severe psycho-behavioral disorders (major psychiatric or neurocognitive disorders)
- Persons admitted to a health or social establishment for purposes other than research
- Contraindications to electrical stimulation:
- Patient with active devices such as pacemakers, defibrillators, insulin pumps, neurostimulators, etc
- Patient with phlebitis or risk of thrombosis
See the full eligibility criteria
- Patients aged 75 or over who have undergone surgery for a fracture of the upper end of the femur
- Hospitalised in the SMR department no later than D14 of their operation
- Resource Iso Group greater than or equal to 3 on the Aggir scale
- Patient capable of consenting who has signed a consent form or patient unable to express consent at the discretion of the principal investigator, informed and not opposed to the study, for whom a trusted person, or if...
- Affiliated to a social security scheme
- Persons deprived of their liberty by a judicial or administrative decision
- Individuals with severe psycho-behavioral disorders (major psychiatric or neurocognitive disorders)
- Persons admitted to a health or social establishment for purposes other than research
- Contraindications to electrical stimulation:
- Patient with active devices such as pacemakers, defibrillators, insulin pumps, neurostimulators, etc
- Patient with phlebitis or risk of thrombosis
- Epileptic patient
- Patient with fragile skin or open wounds on the lower limbs
- Subject participating in another treatment study with an exclusion period still in progress at pre-inclusion.
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 75 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.